欧洲合成生物学市场预测至 2028 年 - COVID-19 影响和区域分析（酶、底物生物、寡核苷酸和异种核酸）、技术（测量和建模、克隆和测序、基因组工程、基因合成、纳米技术、等）和应用（医疗应用、工业应用、食品和农业、环境应用等）
No. of Pages: 170 | Report Code: BMIRE00025389 | Category: Life Sciences
No. of Pages: 170 | Report Code: BMIRE00025389 | Category: Life Sciences
许多初创企业正在涌现发展中国家，因为各国政府正在为合成生物学的国内发展提供资金。 Siolta Therapeutics 生产治疗性微生物菌群来预防和治疗炎症性疾病。它评估临床数据并开发口服补充剂的混合物种疗法。与现有的过敏药物不同，基于微生物组的方法在免疫功能障碍级联发生之前起作用。 STMC-103H 是 Siolta Therapeutics 的旗舰候选治疗药物，目前正在研究治疗过敏性哮喘以及其他慢性炎症性疾病，包括特应性皮炎和过敏性鼻炎。同样，成立于 2017 年的 Kinnva Ltd. 是一家合成生物学初创企业，专注于生物技术、清洁技术和农业技术领域。 Kinnva 采用独特的发酵技术和复杂的加工方法，生产用于食品、饲料、营养保健品和化妆品行业的高价值生化产品。因此，初创企业为该地区合成生物学市场的扩张做出了重大贡献。
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能
推动欧洲合成生物市场。 欧洲合成生物市场预计在预测期内将以显着的复合年增长率增长。
< h3>
欧洲合成生物市场细分
欧洲合成生物学市场根据产品、技术、应用和国家进行分析。根据产品，市场分为酶、底盘生物、寡核苷酸和异种核酸。寡核苷酸领域在 2020 年占据市场主导地位，预计在预测期内将继续以最快的速度增长。根据技术，市场分为测量和测量。建模、克隆和测序、基因组工程、基因合成、纳米技术等。基因合成领域在 2020 年占据市场主导地位，而基因组工程领域预计在预测期内将以最快的复合年增长率增长。根据应用，市场分为医疗应用、工业应用、食品和农业、环境应用等。医疗应用领域在 2020 年占据市场主导地位，预计在预测期内将以最高复合年增长率增长。欧洲合成生物学市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。
安捷伦科技，公司；阿米里斯；法典；金斯瑞生物科技公司；综合 DNA 技术；默克公司；新英格兰生物实验室；诺维信公司；赛默飞世尔科技；和 Twist Bioscience 是欧洲合成生物学市场的领先公司之一。
Strategic insights for Europe Synthetic Biology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,111.58 Million |
| Market Size by 2028 | US$ 11,362.83 Million |
| Global CAGR (2021 - 2028) | 20.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Synthetic Biology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Synthetic Biology Market is valued at US$ 3,111.58 Million in 2021, it is projected to reach US$ 11,362.83 Million by 2028.
As per our report Europe Synthetic Biology Market, the market size is valued at US$ 3,111.58 Million in 2021, projecting it to reach US$ 11,362.83 Million by 2028. This translates to a CAGR of approximately 20.3% during the forecast period.
The Europe Synthetic Biology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Synthetic Biology Market report:
The Europe Synthetic Biology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Synthetic Biology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Synthetic Biology Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Synthetic Biology Market
